A Study of Photon and Proton Chemoradiotherapy As Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

May 10, 2018

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2035

Conditions

Pancreatic Cancer

Interventions

RADIATION

Moderately Hypofractionated RT

Patients will be treated with moderately hypofractionated radiation treatment

Trial Locations (2)

Mayo Clinic in Rochester, Rochester

Mayo Clinic in Arizona, Scottsdale